SIRT2 and metabolic dysfunction-associated steatotic liver disease: In the context of NAFLD pathogenesis, increased SIRT1 expression in response to AICAR treatment was AMPK mediated [45]; nevertheless, no study has explored AICAR’s impact on SIRT2.